Research progress of CAR T-cell in tumor therapy / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 190-194, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-473563
ABSTRACT
Adoptive cell transfusion based on chimeric antigen receptor (CAR) is a new approach for treating malignant diseases and even advanced malignancies. More patients with advanced malignancies are expected to benefit from CAR T-cells once the suitable target molecules are selected, the safe method of gene transduction is applied, and the side effects of CAR T-cells are prevented.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Clinical Oncology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS